Victoria A Ploplis Selected Research

LDL Receptors (LDL Receptor)

1/2018	Characterization of Atherosclerosis Formation in a Murine Model of Type IIa Human Familial Hypercholesterolemia.
5/2006	A fibrinogen deficiency accelerates the initiation of LDL cholesterol-driven atherosclerosis via thrombin generation and platelet activation in genetically predisposed mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Victoria A Ploplis Research Topics

Disease

15	Infections 03/2024 - 08/2003
9	Inflammation (Inflammations) 03/2024 - 12/2006
7	Neoplasms (Cancer) 01/2011 - 02/2003
5	Atherosclerosis 12/2021 - 05/2006
4	Thrombosis (Thrombus) 10/2014 - 12/2006
3	Sepsis (Septicemia) 03/2024 - 01/2015
3	Streptococcal Infections (Streptococcal Infection) 01/2022 - 01/2013
3	Fibrosis (Cirrhosis) 01/2017 - 08/2003
3	Adenoma (Adenomas) 07/2008 - 02/2003
2	Urinary Tract Infections (Urinary Tract Infection) 03/2024 - 09/2023
2	Cross Infection (Nosocomial Infection) 03/2024 - 09/2023
2	Bacterial Infections (Bacterial Infection) 02/2024 - 01/2013
2	Hemolysis 01/2022 - 01/2016
2	Wounds and Injuries (Trauma) 01/2021 - 06/2016
2	Endotoxemia 01/2015 - 01/2011
2	Colonic Neoplasms (Colon Cancer) 01/2011 - 11/2003
2	Necrosis 02/2010 - 12/2006
2	Respiratory Hypersensitivity 05/2009 - 01/2007
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 07/2008 - 11/2003
2	Carcinoma (Carcinomatosis) 11/2003 - 02/2003
2	Carcinogenesis 11/2003 - 02/2003
1	Wound Infection (Wound Infections) 02/2024
1	Communicable Diseases (Infectious Diseases) 02/2024
1	Pulmonary Hypertension 01/2023
1	Vascular Remodeling 01/2023
1	Familial Primary Pulmonary Hypertension 01/2023
1	Hypoxia (Hypoxemia) 01/2023
1	Hypercholesterolemia 12/2021
1	Tics (Tic) 06/2019
1	Hypertension (High Blood Pressure) 01/2017
1	Multiple Trauma (Multiple Injuries) 06/2016
1	Pulmonary Edema 01/2016
1	Lung Injury 01/2016
1	Pathologic Processes 04/2015
1	Acute Kidney Injury (Acute Renal Failure) 01/2015

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2003
7	FibrinIBA 03/2024 - 08/2003
6	Plasminogen Activators (Plasminogen Activator)IBA 01/2017 - 03/2010
5	PlasminogenIBA 12/2021 - 08/2003
4	Fibrinogen (Factor I)FDA Link 03/2024 - 05/2006
4	Thrombin FDA Link 06/2019 - 05/2006
4	Protein CIBA 06/2019 - 12/2006
3	streptolysin SIBA 01/2022 - 01/2016
3	CollagenIBA 01/2017 - 01/2007
3	Plasminogen Activator Inhibitor 1IBA 01/2017 - 03/2010
3	Fibrinolysin FDA Link 01/2017 - 08/2003
3	Adenosine Diphosphate (ADP)IBA 10/2014 - 01/2012
2	RNA (Ribonucleic Acid)IBA 01/2023 - 07/2008
2	Fibrin Fibrinogen Degradation ProductsIBA 01/2022 - 03/2008
2	oxidized low density lipoproteinIBA 12/2021 - 01/2018
2	Virulence Factors (Pathogenicity Factors)IBA 01/2021 - 01/2017
2	LDL CholesterolIBA 01/2018 - 05/2006
2	Apolipoprotein B-100 (Apo B 100)IBA 01/2018 - 05/2006
2	Apolipoprotein B-48IBA 01/2018 - 05/2006
2	ApolipoproteinsIBA 01/2018 - 05/2006
2	LDL Receptors (LDL Receptor)IBA 01/2018 - 05/2006
2	Peptide Hydrolases (Proteases)FDA Link 01/2017 - 01/2011
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2017 - 01/2013
2	Fibronectins (Fibronectin)IBA 01/2017 - 08/2003
2	Thromboplastin (Tissue Factor)IBA 01/2011 - 05/2009
2	Matrix Metalloproteinase 7 (Matrilysin)IBA 01/2011 - 07/2008
2	Sulindac (Copal)FDA LinkGeneric 01/2011 - 07/2008
2	MucinsIBA 05/2009 - 01/2007
2	Factor X (Stuart Factor)IBA 05/2009 - 01/2007
2	Extracellular Matrix ProteinsIBA 08/2003 - 02/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2024
1	Antimicrobial PeptidesIBA 02/2024
1	sphingosine kinaseIBA 01/2023
1	SphingolipidsIBA 01/2023
1	Histones (Histone)IBA 01/2023
1	fibrin fragment D (D-dimer)IBA 01/2022
1	Sodium-Bicarbonate SymportersIBA 01/2022
1	Chloride-Bicarbonate AntiportersIBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 12/2021
1	Apolipoproteins E (ApoE)IBA 12/2021
1	IntegrinsIBA 01/2021
1	Streptokinase FDA Link 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 10/2019
1	ThrombomodulinIBA 06/2019
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 06/2019
1	CytokinesIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	AldosteroneIBA 01/2017
1	Angiotensin IIIBA 01/2017
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2017
1	Enzyme Precursors (Zymogens)IBA 01/2017
1	Complement System Proteins (Complement)IBA 04/2016
1	IonsIBA 01/2016
1	AnionsIBA 01/2016
1	Erythrocyte Anion Exchange Protein 1 (Band 3 Protein)IBA 01/2016
1	Genetic Markers (Genetic Marker)IBA 01/2016
1	AntithrombinsIBA 01/2016
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016
1	lepirudin (Refludan)FDA Link 01/2016
1	Urokinase Plasminogen Activator ReceptorsIBA 04/2015
1	VitronectinIBA 01/2015

Therapy/Procedure

2	Catheters 03/2024 - 09/2023
2	Therapeutics 01/2022 - 06/2016
1	Resuscitation 06/2016